New daily pill tested to better control diabetes and weight
NCT ID NCT06109311
Summary
This study tested a once-daily oral medication called orforglipron for adults with type 2 diabetes whose blood sugar was not well controlled on insulin. It aimed to see if the pill could lower blood sugar and body weight more effectively than a placebo over about 46 weeks. The trial involved 546 participants and was sponsored by Eli Lilly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abe Clinic
Ōita, 870-0039, Japan
-
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212000, China
-
Beijing Hospital
Beijing, Beijing Municipality, 100051, China
-
Bingham Memorial Hospital
Blackfoot, Idaho, 83221, United States
-
C.M.D.T.A. Neomed
Brasov, Brașov County, 500283, Romania
-
CEDOES
Vitória, Espírito Santo, 29055450, Brazil
-
CMI DNBM Dr. Pop Lavinia
Baia Mare, Maramureş, 430222, Romania
-
CMR of Greater New Haven, LLC
Hamden, Connecticut, 06517, United States
-
CPQuali Pesquisa Clínica
São Paulo, 01228-000, Brazil
-
Care Access - Brandon
Brandon, Florida, 33510, United States
-
Centro Multidisciplinar de Estudos Clinicos
São Bernardo do Campo, São Paulo, 09715-090, Brazil
-
Centro de Endocrinologia y Nutricion
Caguas, 00725, Puerto Rico
-
Centro de Pesquisa Sao Lucas
Campinas, São Paulo, 13060-803, Brazil
-
Centrul Medical Endocrinologie si Diabet Dr. Paveliu
Bucharest, București, 50538, Romania
-
Centrul Medical NutriLife
Bucharest, București, 013764, Romania
-
Chongqing General Hospital
Chongqing, Chongqing Municipality, 401147, China
-
Clinica Korall
Satu Mare, 440055, Romania
-
Clinvest Headlands Llc
Springfield, Missouri, 65807, United States
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, 66606, United States
-
Diabdana
Oradea, Bihor County, 410147, Romania
-
Diamed Obesity
Galați, 800291, Romania
-
Encore Medical Research
Hollywood, Florida, 33024, United States
-
Encore Medical Research - Weston
Weston, Florida, 33331, United States
-
FDI Clinical Research
San Juan, 00927, Puerto Rico
-
Frontier Clinical Research, LLC
Scottdale, Pennsylvania, 15683, United States
-
Fukuwa Clinic
Chuo-ku, Tokyo, 104-0031, Japan
-
Geea Medical Easy Diet
Bucharest, București, 010627, Romania
-
Hasegawa Medical Clinic
Chitose, Hokkaido, 066-0032, Japan
-
IBPClin - Instituto Brasil de Pesquisa Clínica
Rio de Janeiro, 20241-180, Brazil
-
ISPEM - Instituto São José dos Campos em Pesquisas Médicas
São José dos Campos, São Paulo, 12243-280, Brazil
-
Insight Centro de Pesquisas
Porto Alegre, Rio Grande do Sul, 90560-003, Brazil
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Jinnouchi Hospital
Kumamoto, 862-0976, Japan
-
Kansai Electric Power Hospital
Osaka, 553-0003, Japan
-
L2IP - Instituto de Pesquisas Clínicas
Brasília, Federal District, 70200730, Brazil
-
Lifedoc Research - Lenox Park Drive
Memphis, Tennessee, 38115, United States
-
Loma Linda University Health System
Loma Linda, California, 92350, United States
-
MD First Research - Chandler
Chandler, Arizona, 85286, United States
-
Matoba Internal Medicine Clinic
Ebina, Kanagawa, 243-0432, Japan
-
Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
Toluca Lake, California, 91602, United States
-
Medical Corporation Sato Medical clinic
Ootaku, Tokyo, 143-0015, Japan
-
Milena Sante
Galați, 800001, Romania
-
MinamiAkatsukaClinic
Mito, Ibaraki, 311-4153, Japan
-
Nanjing First Hospital
Nanjing, Jiangsu, 210012, China
-
Orita Clinical Research
Decatur, Georgia, 30034, United States
-
Phoenix Clinical LLC
Phoenix, Arizona, 85014, United States
-
Quanta Diagnóstico e Terapia
Curitiba, Paraná, 80040-110, Brazil
-
Richmond University Medical Center
Staten Island, New York, 10310, United States
-
SC Dentosim Queen SRL - Centrul Medical Diamed
Târgu Mureş, Mureș County, 540098, Romania
-
SanRo Clinical Research Group
Bryant, Arkansas, 72022, United States
-
Shiraiwa Medical Clinic
Kashihara, Osaka, 582-0005, Japan
-
St. Luke's Humphreys Diabetes Center: Boise
Boise, Idaho, 83702, United States
-
Takai Internal Medicine Clinic
Kamakura-shi, Kanagawa, 247-0056, Japan
-
Tama Center Clinic Mirai
Tama, Tokyo, 206-0633, Japan
-
Texas Valley Clinical Research
Weslaco, Texas, 78596, United States
-
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang Shi, Henan, 471003, China
-
The Institute of Medical Science, Asahi Life Foundation
Chuo-ku, Tokyo, 103-0002, Japan
-
The Research Group of Lexington
Lexington, Kentucky, 40503, United States
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
-
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450014, China
-
The Second People's Hospital of Hefei
Hefei, Anhui, 230011, China
-
Tokuyama Clinic
Mihama-ku,Chiba City, Chiba, 261-0004, Japan
-
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, 103-0027, Japan
-
Tristar Clinical Investigations
Philadelphia, Pennsylvania, 19114, United States
-
Velocity Clinical Research, Gardena
Gardena, California, 90247, United States
-
Velocity Clinical Research, Medford
Medford, Oregon, 97504, United States
-
Velocity Clinical Research, Mt. Auburn
Cincinnati, Ohio, 45219, United States
-
Wannan Medical College Yijishan Hospital
Wuhu, Anhui, 241001, China
-
Western University of Health Sciences
Pomona, California, 91766, United States
Conditions
Explore the condition pages connected to this study.